An Overview of the Effect of Sodium Glucose Cotransporter 2 Inhibitor Monotherapy on Glycemic and Other Clinical Laboratory Parameters in Type 2 Diabetes Patients
Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s112236
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2016
Authors
Publisher
Informa UK Limited